Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Neoplasm Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06466187
What this trial is testing

SGN-MesoC2 in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more
Seagen, a wholly owned subsidiary of Pfizer 19
Large-scale testing (Phase 3)Study completedNCT01774721
What this trial is testing

ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.

Who this might be right for
Non-small Cell Lung Cancer With EGFR-Activating Mutations
Pfizer 452
Testing effectiveness (Phase 2)Study completedNCT04314895
What this trial is testing

Trial of NanoPac Intratumoral Injection in Lung Cancer

Who this might be right for
Lung Cancer, Nonsmall CellLung CancerLung Cancer, Small Cell+1 more
NanOlogy, LLC 18
Testing effectiveness (Phase 2)Study completedNCT01211275
What this trial is testing

Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
The Netherlands Cancer Institute 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362
What this trial is testing

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Who this might be right for
Urinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more
BicycleTx Limited 329
Testing effectiveness (Phase 2)Study completedNCT00284141
What this trial is testing

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Who this might be right for
Pulmonary DiseasesNeoplasms, Lung
Sanofi 98
Testing effectiveness (Phase 2)Active Not RecruitingNCT04516070
What this trial is testing

Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis

Who this might be right for
Metastatic Lung Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 55
Not applicableLooking for participantsNCT05875870
What this trial is testing

Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer

Who this might be right for
Lung NeoplasmEsophageal Neoplasms
Taipei Veterans General Hospital, Taiwan 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT05310539
What this trial is testing

Early Recovery After "Wedge Resection" Surgery to Remove Lung Mestastasis Secondary to Bone Cancer.

Who this might be right for
Metastasis LungBone Neoplasm
Istituto Ortopedico Rizzoli 75
Post-approval studies (Phase 4)WithdrawnNCT02975921
What this trial is testing

Betadine Pleurodesis Via Tunneled Pleural Catheters

Who this might be right for
Pleural EffusionPleurodesisMalignant Pleural Effusion+3 more
Yale University
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Not applicableWithdrawnNCT04555564
What this trial is testing

Tc99m Macroaggregated Albumin Bronchial Artery Study

Who this might be right for
HemoptysisMalignant NeoplasmLung Cancer
Johns Hopkins University
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Ended earlyNCT02122146
What this trial is testing

PF-06664178 In Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 31
Not applicableLooking for participantsNCT07543601
What this trial is testing

Enhanced COPD Management in Suspected Lung Cancer Patients

Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)Lung Cancer (Diagnosis)Lung Neoplasm Malignant+9 more
Ditte Krag-Hansen 280
Testing effectiveness (Phase 2)Study completedNCT02397928
What this trial is testing

Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

Who this might be right for
Malignant Pleural Mesothelioma
NovoCure Ltd. 82
Early research (Phase 1)Study completedNCT00514007
What this trial is testing

Study of Continuous OSI-906 Dosing

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Early research (Phase 1)Study completedNCT02592577
What this trial is testing

MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerCarcinoma
Adaptimmune 28
Next Page